Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppina Miele

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
International Journal of Environmental Research and Public Health|August 7, 2021
CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with OcrelizumabGianmarco Abbadessa, Giuseppina Miele, Paola Cavalla, et al.
Multiple Sclerosis and Related Disorders|May 10, 2023
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosisGianmarco Abbadessa, Marta Ponzano, Floriana Bile, et al.
Journal of Neurology|May 4, 2024
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched studyAurora Zanghì, Giovanna Borriello, Simona Bonavita, et al.
Journal of the Neurological Sciences|August 6, 2025
Serum miRNAs as biomarkers in Neurofibromatosis 1: New promising findingsFilomena Napolitano, Gianmarco Abbadessa, Milena Dell'Aquila, et al.
Journal of Clinical Medicine|March 11, 2023
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World EvidenceElisabetta Signoriello, Giacomo Lus, Francesco Saccà, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 25, 2022
Telemedicine application to headache: a critical reviewEmanuele Spina, Gioacchino Tedeschi, Antonio Russo, et al.
Therapeutic Advances in Chronic Disease|August 9, 2021
Digital work engagement among Italian neurologistsFrancesco Brigo, Marta Ponzano, Maria Pia Sormani, et al.
Journal of Neurology|December 12, 2024
Behind the scenes: exploring neurological journal editors' work habits, decisions, and potential sources of conflict of interestElisabetta Maida, Gianmarco Abbadessa, Francesco Di Lorenzo, et al.
Journal of Clinical Medicine|April 23, 2022
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter StudyRoberta Lanzillo, Antonio Carotenuto, Elisabetta Signoriello, et al.
International Journal of Medical Informatics|June 10, 2026
Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital surveyLuigi Lavorgna, Giuseppina Miele, Marta Ponzano, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Environmental Research and Public Health|August 7, 2021
CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with OcrelizumabGianmarco Abbadessa, Giuseppina Miele, Paola Cavalla, et al.
Multiple Sclerosis and Related Disorders|May 10, 2023
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosisGianmarco Abbadessa, Marta Ponzano, Floriana Bile, et al.
Journal of Neurology|May 4, 2024
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched studyAurora Zanghì, Giovanna Borriello, Simona Bonavita, et al.
Journal of the Neurological Sciences|August 6, 2025
Serum miRNAs as biomarkers in Neurofibromatosis 1: New promising findingsFilomena Napolitano, Gianmarco Abbadessa, Milena Dell'Aquila, et al.
Journal of Clinical Medicine|March 11, 2023
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World EvidenceElisabetta Signoriello, Giacomo Lus, Francesco Saccà, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 25, 2022
Telemedicine application to headache: a critical reviewEmanuele Spina, Gioacchino Tedeschi, Antonio Russo, et al.
Therapeutic Advances in Chronic Disease|August 9, 2021
Digital work engagement among Italian neurologistsFrancesco Brigo, Marta Ponzano, Maria Pia Sormani, et al.
Journal of Neurology|December 12, 2024
Behind the scenes: exploring neurological journal editors' work habits, decisions, and potential sources of conflict of interestElisabetta Maida, Gianmarco Abbadessa, Francesco Di Lorenzo, et al.
Journal of Clinical Medicine|April 23, 2022
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter StudyRoberta Lanzillo, Antonio Carotenuto, Elisabetta Signoriello, et al.
International Journal of Medical Informatics|June 10, 2026
Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital surveyLuigi Lavorgna, Giuseppina Miele, Marta Ponzano, et al.
Pageof 5